Navigation Links
Pharmalink AB Strengthens Senior Management Team
Date:10/29/2012

STOCKHOLM, October 29, 2012 /PRNewswire/ --

Dr. Heather Cook Appointed Director of Regulatory Affairs and Marek Poszepczynski as Director of Business Development

Pharmalink AB, a Swedish specialty pharma company, today announces it has appointed Dr. Heather Cook as Director of Regulatory Affairs and Mr. Marek Poszepczynski as Director of Business Development.

Dr. Cook brings to Pharmalink over 15 years of experience within the pharmaceutical industry, with a proven track record in global regulatory affairs and clinical development. Prior to joining Pharmalink, Dr. Cook was Head of Department for Regulatory Development Projects at H. Lundbeck A/S. She was also Global Regulatory Affairs Director, Oncology for Astra Zeneca and held a number of other senior roles including Scientific Director for Neuroscience and Infection. She has worked in the UK, Canada, and Denmark and currently resides in Stockholm.  Dr. Cook is also Partner, Pharma and Biotech R&D consultant at PharmaView Consulting HB. She has a PhD in Zoology from the University of Toronto and is completing an MBA at Stockholm School of Economics.

Marek Poszepczynski joins Pharmalink after a career spanning 10 years and combining financial and business development experience. Before joining Pharmalink, Mr. Poszepczynski was lead equity analyst at Handelsbanken covering European and Swedish biotechnology stocks.  Prior to Handelsbanken, Mr. Poszepczynski was Vice President of Business Development at Karolinska Development, where he carried out a wide variety of tasks including streamlining the company's business operations as well as taking part in M&A, licensing and fund raising negotiations. Mr. Poszepczynski spent six years at BioVitrum AB where he was Director of Corporate Development, and part of the in-and-out licensing deals team of the company's R&D portfolio. Mr. Poszepczynski holds a Master of Industrial Engineering and Business Management from KTH Royal Institute of Technology, Stockholm.

Pharmalink's Managing Director Johan Häggblad said, "These appointments add significant talent and new experience to Pharmalink's management team as the Company continues to drive forward its late stage clinical development programs for Nefecon® and Busulipo™ and actively seeks new product opportunities. It is a measure of our reputation that such high caliber executives have joined us and I look forward to working with Heather and Marek through what is an exciting stage of development."

About Pharmalink

Pharmalink is a Swedish specialty pharma company developing high value products for niche indications. Pharmalink draws on its extensive experience of pharmaceutical development and marketing and the excellence of medical science in Sweden to identify and progress products that address significant unmet medical needs. With a successful history in pharmaceutical sales and marketing, and highly experienced, dynamic management team, Pharmalink is currently focused on the development of valuable, de-risked projects using a repurposing and reformulation strategy. It has two late-stage clinical phase products under development, Nefecon® and Busulipo™, having successfully divested its Xepol® product in 2010. Pharmalink is actively seeking opportunities to acquire or in-licence product opportunities in niche and hospital care indications. Visit http://www.pharmalink.se for further information.

For further information, please contact:

Pharmalink AB:
Johan Häggblad, Managing Director, +46(0)70-668-0644
Email: johan.haggblad@pharmalink.se
http://www.pharmalink.se

Citigate Dewe Rogerson:
Chris Gardner/Nina Enegren, +44-207-638-9571



'/>"/>
SOURCE Pharmalink AB
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmalink Consulting Appoints Chief Operating Officer for the Americas
2. Actinium Pharmaceuticals Strengthens Management Team
3. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
4. RxAlly Strengthens Leadership Team With New Chief Information Officer Mike Groh
5. Tris Pharma Expands Manufacturing Capacity and Strengthens Supply Chain to Support New and Pending Approvals
6. CareFusion Strengthens U.K. Presence With Acquisition of Medical Products Distributor
7. Tina Fehr, Senior Product Manager For AmLactin, Upsher-Smith Laboratories Named PM360 Trailblazer Winner For Womens Health Brand Manager
8. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
9. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
10. Sequenom Announces Exercise In Full Of Over-Allotment Option And Completion Of Offering Of $130 Million Of 5.00% Convertible Senior Notes
11. Safe Driving Prescription for Senior Drivers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , Mar 24, 2017 Research and ... - Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics ... , Europe , Asia-Pacific , ... forecasts are provided for the period 2015 through 2022. Also, a six-year ...
(Date:3/24/2017)... March 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... Commitment Term Sheet (the "Definitive Financing") it entered ... the Company,s stockholders, who are referred to in ... Form 8-K filed with the Securities and Exchange ...
(Date:3/23/2017)... PUNE, India , March 23, 2017 ... are growing ageing population, increasing diabetic population, accelerating economic growth ... developments of this industry are higher life expectancy of ESRD ... potential in emerging markets. However, the expansion of the market ... ...
Breaking Medicine Technology:
(Date:3/24/2017)... , ... March 24, 2017 , ... The law firm ... Plains, N.Y., is pleased to announce Westchester resident Lauren C. Enea has joined the ... for the firm, will concentrate her practice in elder law, Medicaid planning and applications, ...
(Date:3/24/2017)... ... March 24, 2017 , ... Judy Buchanan, co-owner of ... Frederick, MD. Judy says, “I am passionate about sharing Reiki as a holistic, ... difficult and challenging time.” , A Certified Medical Reiki™ Master trained by Raven ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of Saints: A ... God in congregations across the United States. “The Communion of Saints” is ... who has served congregations in seven states throughout his long career of devotion ...
(Date:3/23/2017)... ... March 23, 2017 , ... The physicians of KSF ... the greater Houston Area. The new location is located at 2255 E. Mossy Oaks ... Springwoods Village. This newest location will provide patients living in the north Houston area ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The IoT ... and WiFi connectivity are making a huge impact on businesses and individual consumers alike. ... estimates the IoT will have a value anywhere from $4 trillion to $11 trillion ...
Breaking Medicine News(10 mins):